[HTML][HTML] Should EMT of cancer cells be understood as epithelial-myeloid transition?

HM Schramm - Journal of Cancer, 2014 - ncbi.nlm.nih.gov
HM Schramm
Journal of Cancer, 2014ncbi.nlm.nih.gov
Cancer cells express epithelial markers, and when progressing in malignancy they may
express markers of the mesenchymal cell type. Therefore an epithelial-mesenchymal
transition of the cancer cells is assumed. However the mesenchymal markers can equally
well be interpreted as myeloid markers since they are common in both types of cell lineages.
Moreover, cancer cells express multiple specific markers of the myeloid lineages thus giving
rise to the hypothesis that the transition of cancer cells may be from epithelial to myeloid …
Abstract
Cancer cells express epithelial markers, and when progressing in malignancy they may express markers of the mesenchymal cell type. Therefore an epithelial-mesenchymal transition of the cancer cells is assumed. However the mesenchymal markers can equally well be interpreted as myeloid markers since they are common in both types of cell lineages. Moreover, cancer cells express multiple specific markers of the myeloid lineages thus giving rise to the hypothesis that the transition of cancer cells may be from epithelial to myeloid cells and not to mesenchymal cells. This interpretation would better explain why cancer cells, often already in their primary cancer site, frequently show properties common to those of macrophages, platelets and pre-/osteoclasts.
ncbi.nlm.nih.gov